Innovotech Inc.

Innovotech Inc.

October 03, 2005 13:01 ET

Innovotech Inc.: MBEC BioProducts Inc. to present at BioContact 2005 conference in Quebec City, Friday October 7, 2005

EDMONTON, ALBERTA--(CCNMatthews - Oct. 3, 2005) - Innovotech Inc. (TSX VENTURE:IOT) is pleased to announce that its wholly owned subsidiary, MBEC BioProducts Inc., a developer of anti-microbial biofilm products, will present at BioContact 2005 conference in Quebec City. Ken Boutilier, MBEC's President will offer an overview of the company in the Jacques Cartier Room, Hotel Chateau Frontenac, at 11:30am.

About MBEC BioProducts

MBEC's expertise is microbial biofilms, an emerging field in infection and infection control, with implications in microbial resistance, antibiotic development and diagnostic testing. The Center for Disease Control and Prevention has stated that over 60% of all human infections are caused by biofilms (CDC, 2000). The company's patented technology, the MBEC Assay is a high-throughput system to grow biofilms and subsequently conduct susceptibility tests on antimicrobial candidates with anti-biofilm activity. The company uses this technology in its R&D program to develop products and tests. The company runs a profitable contract research business, serving the biofilm testing needs of the largest catheter and stent manufacturers in the world.

About Innovotech, Inc.

Innovotech Inc. is a public company focused on acquiring novel technologies, or promising technology based companies with an existing or imminent revenue stream. In addition to financial investment in these technologies, Innovotech provides management and technology commercialization expertise.

The TSX Venture Exchange does not accept responsibility for the adequacy or accuracy of this release.

Contact Information

  • Innovotech Inc.
    Dr Gerard Tertzakian
    (780) 448-0585
    (780) 424-0941 (FAX)
    MBEC BioProducts Inc.
    Ken Boutilier
    (780) 425-7717
    (780) 424-0941 (FAX)